Supplement encyclopedia

Calcium

Calcium is an essential mineral obtained from food. Supplements use various calcium compounds, including carbonate and citrate.

Double-check the conclusions and examine the sources before choosing a supplement.

Main conclusion

What it may offer

  • Calcium supplements may slightly increase bone density in adults over 50. In some studies, calcium was taken together with vitamin D.
  • Calcium together with vitamin D slightly reduced fracture risk on average in adults, most of whom lived at home. After one influential study was excluded, the results for any fracture and hip fracture became uncertain.
  • Calcium without vitamin D showed no clear reduction in the overall risk of fractures or falls. Its effect on hip fracture risk remained uncertain.
  • Calcium carbonate may reduce PMS symptoms. In a study of women with PMS, taking 1200 mg of elemental calcium daily for three cycles reduced symptoms more than placebo.
  • In healthy men aged 40 and over without osteoporosis, calcium citrate taken for two years showed no clear reduction in cramps or improvement in handgrip strength compared with placebo.
  • In the third trimester of pregnancy, calcium carbonate may slightly reduce the frequency of leg cramps. A small study found no clear reduction in their intensity.
  • In people with overweight or obesity, calcium supplements showed no clear change in total body weight or fat mass. Waist circumference decreased by about 0.5 cm on average.
  • In people with normal blood pressure, increasing calcium intake through supplements or fortified foods was associated with a small average reduction in blood pressure, about 1–2 mmHg.
  • In breastfeeding women, calcium showed no clear average improvement in bone density in the lumbar spine and forearm. In a separate study of women whose initial dietary calcium intake averaged about 560 mg daily, hip bone density increased more with supplementation between three and 12 months after childbirth, mainly after breastfeeding had ended.

[1] [2] [3] [4] [5] [6] [7] [8] [9]

What was studied

  • Calcium has been studied for bone density, fractures, PMS symptoms, and cramps. You can focus on the result for the goal that matters to you.
  • The studies included different groups, including adults over 50, pregnant women, and breastfeeding women. Compare your situation with the group in which the supplement was studied.

[1] [2] [3] [4] [5] [6] [7]

Which forms were considered

  • Supplements use calcium carbonate and calcium citrate. Check the amount of elemental calcium on the label: its proportion of the salt’s weight differs between these forms.
  • Carbonate is best taken with food, especially with low stomach acidity; citrate can also be taken without food. The fraction of a supplement absorbed is higher with no more than 500 mg of elemental calcium at a time.
  • Fracture studies used calcium alone and in combination with vitamin D. Check the product’s composition when choosing.

[1] [2]

How to get it from food

  • A 170 g portion of plain low-fat yogurt contains about 311 mg of calcium, and 28 g of part-skim mozzarella about 219 mg. Dairy products help provide calcium through ordinary food.
  • An 85 g portion of sardines canned in oil, drained solids with bones, contains about 325 mg of calcium. The soft edible bones are included in this portion.
  • A 126 g portion of firm tofu made with calcium sulfate and nigari contains about 253 mg of calcium. Tofu composition varies, so check the package for the amount in a particular product.

[1] [2] [3]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Bone mineral density in adults over 50In a review of adults over 50, calcium supplements, with vitamin D in some studies, were associated with a small increase in bone density. Fractures need to be assessed separately.Bone mineral density increased by about 0.7–1.8%, depending on the site and duration; calcium supplements, with vitamin D in some studies.
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.
5151 trials in the reviewCalcium intake and bone mineral density: systematic review and meta-analysis ↗adults over 50, review of 59 RCTs, 51 supplement comparisons
  1. Calcium intake and bone mineral density: systematic review and meta-analysis ↗
Any fracture: calcium with vitamin DCalcium combined with vitamin D slightly reduced the risk of any fracture compared with placebo or no supplement. After one influential trial was excluded, the result became uncertain.RR 0.91 (95% CI 0.84–0.99); about 1 percentage point lower; after excluding an influential trial, 0.96 (0.91–1.01)
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.
1515 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗15 RCTs, 51 126 participants, predominantly living at home
  1. Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
Hip fractures: calcium with vitamin DIn the groups studied, calcium combined with vitamin D showed a small average reduction in hip fracture risk compared with placebo or no supplement. After one influential trial was excluded, the risk reduction became uncertain.RR 0.84 (95% CI 0.74–0.96); about 0.3 percentage points lower; after excluding one influential trial, RR 0.88 (95% CI 0.75–1.05).
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.
99 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗adults in combination trials, predominantly living at home
  1. Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Intake and studied regimens
ContextInformation
Intake recommendationsThe US recommended daily allowance of elemental calcium from food, drinks, and supplements is 1000 mg for adults aged 19–50; at 51–70, 1200 mg for women and 1000 mg for men; over 70, 1200 mg.
Intake recommendationsThe US recommended daily allowance of calcium from all sources is 700 mg at 1–3 years, 1000 mg at 4–8 years, and 1300 mg at 9–18 years. For infants, an adequate intake (AI), rather than a recommended dietary allowance (RDA), is established: 200 mg at 0–6 months and 260 mg at 7–12 months. During pregnancy and breastfeeding, the allowance is 1300 mg at 14–18 years and 1000 mg daily at 19–50 years.

Calcium - Health Professional Fact Sheet ↗

Forms

Carbonate contains about 40% elemental calcium by weight, citrate about 21%. The supplement label states the amount of elemental calcium. The fraction absorbed is higher when no more than 500 mg of elemental calcium is taken at once. Carbonate is best taken with food, especially with low stomach acidity; citrate can also be taken without food.

Guidance for each goal

Bone mineral density in adults over 502/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

In a review of adults over 50, calcium supplements, with vitamin D in some studies, were associated with a small increase in bone density. Fractures need to be assessed separately.

Study findings. In a review of adults over 50, calcium supplements, with vitamin D in some studies, were associated with a small increase in bone density. Fractures need to be assessed separately.

Studied regimenvarious doses, salts, and background vitamin D intakecalcium supplements, some with vitamin D
Duration and populationsites and durations varied, including 1–2 yearsadults over 50, review of 59 RCTs, 51 supplement comparisons

Comparison: control in individual trials

Any fracture: calcium with vitamin D2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

Calcium combined with vitamin D slightly reduced the risk of any fracture compared with placebo or no supplement. After one influential trial was excluded, the result became uncertain.

Study findings. Calcium combined with vitamin D slightly reduced the risk of any fracture compared with placebo or no supplement. After one influential trial was excluded, the result became uncertain.

Studied regimendoses and forms variedcalcium plus vitamin D
Duration and populationindividual trial durations varied15 RCTs, 51 126 participants, predominantly living at home

Comparison: placebo or no supplement

Hip fractures: calcium with vitamin D2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

In the groups studied, calcium combined with vitamin D showed a small average reduction in hip fracture risk compared with placebo or no supplement. After one influential trial was excluded, the risk reduction became uncertain.

Study findings. In the groups studied, calcium combined with vitamin D showed a small average reduction in hip fracture risk compared with placebo or no supplement. After one influential trial was excluded, the risk reduction became uncertain.

Studied regimenvarious dosescalcium plus vitamin D
Duration and populationtrial durations variedadults in combination trials, predominantly living at home

Comparison: placebo or no supplement

Any fracture: calcium alone3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: The CI allows a small benefit and no effect. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast.

No clear reduction in the risk of any fracture was found with calcium alone compared with placebo or no supplement.

Study findings. No clear reduction in the risk of any fracture was found with calcium alone compared with placebo or no supplement.

Studied regimenDoses variedCalcium supplements alone, various salts
Duration and populationDurations varied, averaging 2.8 years in 15 calcium studiesAdults, predominantly living at home, 9067 in 11 RCTs

Comparison: Placebo or no supplement

Hip fractures: calcium alone1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: The interval allows benefit and a substantial increase in risk. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Limitations of individual RCTs.

The effect of calcium alone on hip fracture risk remains very uncertain.

Study findings. The effect of calcium alone on hip fracture risk remains very uncertain.

Studied regimenDoses variedCalcium supplements alone, various salts
Duration and populationDurations varied, averaging 2.8 years in 15 calcium studiesAdults, predominantly living at home, 6703 in 6 RCTs

Comparison: Placebo or no supplement

Nonvertebral fractures: calcium alone3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: The CI allows effects in either direction. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast.

In the calcium-alone analysis, the estimate of nonvertebral fracture risk allowed both a decrease and an increase compared with control.

Study findings. In the calcium-alone analysis, the estimate of nonvertebral fracture risk allowed both a decrease and an increase compared with control.

Studied regimenDoses variedCalcium supplements alone, various salts
Duration and populationDurations varied, averaging 2.8 years in 15 calcium studiesAdults, predominantly living at home, 3204 in 4 RCTs

Comparison: Placebo or no supplement

Vertebral fractures: calcium alone3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: The CI includes no effect and possible benefit. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast.

In the calcium-alone analysis, the estimate of vertebral fracture risk allowed both a decrease and an increase compared with control.

Study findings. In the calcium-alone analysis, the estimate of vertebral fracture risk allowed both a decrease and an increase compared with control.

Studied regimenDoses variedCalcium supplements alone, various salts
Duration and populationDurations varied, averaging 2.8 years in 15 calcium studiesAdults, predominantly living at home, 6576 in 10 RCTs

Comparison: Placebo or no supplement

At least one fall: calcium alone3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: Limited precision for the effect on risk. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast.

No clear reduction in the probability of at least one fall was found with calcium alone compared with placebo or no supplement.

Study findings. No clear reduction in the probability of at least one fall was found with calcium alone compared with placebo or no supplement.

Studied regimenDoses variedCalcium supplements alone, various salts
Duration and populationDurations varied, averaging 2.8 years in 15 calcium studiesAdults, predominantly living at home, 2966 in 2 RCTs

Comparison: Placebo or no supplement

Rate of falls: calcium alone3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: No separate downgrade is required for the stated wording. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Two studies, including limitations in measuring recurrent events.

No clear reduction in the rate of falls was found with calcium alone compared with placebo or no supplement.

Study findings. No clear reduction in the rate of falls was found with calcium alone compared with placebo or no supplement.

Studied regimenDoses variedCalcium supplements alone, various salts
Duration and populationDurations varied, averaging 2.8 years in 15 calcium studiesAdults, predominantly living at home, 1794 in 2 RCTs

Comparison: Placebo or no supplement

Total bone mineral content in children and adolescents2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

In healthy children and adolescents, a review found a small increase in total bone mineral content compared with control. This outcome did not determine the effect on future fractures.

Study findings. In healthy children and adolescents, a review found a small increase in total bone mineral content compared with control. This outcome did not determine the effect on future fractures.

Studied regimendifferent amounts and formscalcium supplements and dietary interventions in individual studies
Duration and populationSupplements for at least 3 months; bone outcomes measured after at least 6 months of follow-uphealthy children and adolescents, review of 19 RCTs, 2859 participants

Comparison: placebo or control

Femoral neck and lumbar spine bone density in children and adolescents2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

In healthy children and adolescents, no clear advantage of calcium over control was found for femoral neck or lumbar spine bone density.

Study findings. In healthy children and adolescents, no clear advantage of calcium over control was found for femoral neck or lumbar spine bone density.

Studied regimenvarious dosescalcium from food or supplements, depending on the study
Duration and populationSupplements for at least 3 months; bone outcomes measured after at least 6 months of follow-uphealthy children and adolescents in the RCTs in the review

Comparison: control

Nonvertebral fractures: calcium with vitamin D2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: Uncertainty about a small effect for an individual outcome. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: The result is limited by the original RCTs and the sensitivity of individual outcomes to an influential trial.

In the overall analysis, calcium with vitamin D reduced nonvertebral fracture risk compared with control. After one influential trial was excluded, the reduction became uncertain.

Study findings. In the overall analysis, calcium with vitamin D reduced nonvertebral fracture risk compared with control. After one influential trial was excluded, the reduction became uncertain.

Studied regimenDoses and forms variedCalcium together with vitamin D
Duration and populationDurations variedAdults, predominantly living at home, 10324 in 7 RCTs

Comparison: Placebo or no supplement

Vertebral fractures: calcium with vitamin D2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: Uncertainty about a small effect for an individual outcome. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: The result is limited by the original RCTs and the sensitivity of individual outcomes to an influential trial.

The estimate of vertebral fracture risk with calcium and vitamin D allowed both a decrease and an increase compared with control.

Study findings. The estimate of vertebral fracture risk with calcium and vitamin D allowed both a decrease and an increase compared with control.

Studied regimenDoses and forms variedCalcium together with vitamin D
Duration and populationDurations variedAdults, predominantly living at home, 42185 in 4 RCTs

Comparison: Placebo or no supplement

At least one fall: calcium with vitamin D2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: Uncertainty about a small effect for an individual outcome. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: The result is limited by the original RCTs and the sensitivity of individual outcomes to an influential trial.

A reduction in the probability of at least one fall with calcium and vitamin D compared with control remains uncertain.

Study findings. A reduction in the probability of at least one fall with calcium and vitamin D compared with control remains uncertain.

Studied regimenDoses and forms variedCalcium together with vitamin D
Duration and populationDurations variedAdults, predominantly living at home, 11068 in 10 RCTs

Comparison: Placebo or no supplement

Rate of falls: calcium with vitamin D2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: Uncertainty about a small effect for an individual outcome. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: The result is limited by the original RCTs and the sensitivity of individual outcomes to an influential trial.

No clear difference in the rate of falls was found between calcium combined with vitamin D and control.

Study findings. No clear difference in the rate of falls was found between calcium combined with vitamin D and control.

Studied regimenDoses and forms variedCalcium together with vitamin D
Duration and populationDurations variedAdults, predominantly living at home, 7532 in 4 RCTs

Comparison: Placebo or no supplement

Overall severity of premenstrual symptoms2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

Over three menstrual cycles, calcium carbonate reduced overall premenstrual symptoms in women with PMS more than placebo.

Study findings. Over three menstrual cycles, calcium carbonate reduced overall premenstrual symptoms in women with PMS more than placebo.

Studied regimen1200 mg of elemental calcium/daycalcium carbonate
Duration and populationthree menstrual cycles497 women with PMS randomized, 466 in the efficacy analysis

Comparison: placebo

Pain in primary dysmenorrhea: calcium alone1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: Small groups. The pain difference depends on the analysis, or the CI allows substantially different effects. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: One small RCT, multiple comparisons, and disagreement between the longitudinal test and the pairwise pain result.

The adjusted estimate of menstrual pain was lower with calcium than with placebo; the analysis of pain changes over time between groups leaves the effect uncertain.

Study findings. The adjusted estimate of menstrual pain was lower with calcium than with placebo; the analysis of pain changes over time between groups leaves the effect uncertain.

Studied regimen1000 mg of calcium as worded in the abstractCalcium alone, tablet
Duration and populationFrom day 15 of the cycle until pain stopped during the next menstruation, three cycles85 female students with moderate or severe primary dysmenorrhea, three groups

Comparison: Matched placebo

Pain in primary dysmenorrhea: calcium with vitamin D31/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: Small groups. The pain difference depends on the analysis, or the CI allows substantially different effects. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: One small RCT, multiple comparisons, and disagreement between the longitudinal test and the pairwise pain result.

No clear reduction in menstrual pain was found with calcium combined with vitamin D3 compared with placebo.

Study findings. No clear reduction in menstrual pain was found with calcium combined with vitamin D3 compared with placebo.

Studied regimen1000 mg of calcium + 5000 IU of D3Calcium with D3, tablet
Duration and populationFrom day 15 of the cycle until pain stopped during the next menstruation, three cycles85 female students with moderate or severe primary dysmenorrhea, three groups

Comparison: Matched placebo

Menstrual blood loss: calcium alone1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: Small groups. The pain difference depends on the analysis, or the CI allows substantially different effects. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: One small RCT, multiple comparisons, and disagreement between the longitudinal test and the pairwise pain result.

The pictorial-scale estimate of menstrual blood loss allowed both a decrease and an increase with calcium alone compared with placebo.

Study findings. The pictorial-scale estimate of menstrual blood loss allowed both a decrease and an increase with calcium alone compared with placebo.

Studied regimen1000 mg of calcium as worded in the abstractCalcium alone, tablet
Duration and populationFrom day 15 of the cycle until pain stopped during the next menstruation, three cycles85 female students with moderate or severe primary dysmenorrhea, three groups

Comparison: Matched placebo

Menstrual blood loss: calcium with vitamin D31/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: Small groups. The pain difference depends on the analysis, or the CI allows substantially different effects. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: One small RCT, multiple comparisons, and disagreement between the longitudinal test and the pairwise pain result.

The pictorial-scale estimate of menstrual blood loss allowed both a decrease and an increase with calcium and vitamin D3 compared with placebo.

Study findings. The pictorial-scale estimate of menstrual blood loss allowed both a decrease and an increase with calcium and vitamin D3 compared with placebo.

Studied regimen1000 mg of calcium + 5000 IU of D3Calcium with D3, tablet
Duration and populationFrom day 15 of the cycle until pain stopped during the next menstruation, three cycles85 female students with moderate or severe primary dysmenorrhea, three groups

Comparison: Matched placebo

Cramps in men aged 40 and over2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: No CI for the contrast is reported. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Secondary outcome, cramps assessed by questionnaire.

At the two-year visit, cramps during the preceding six months were reported by 47% of men on placebo, 43% on 600 mg, and 51% on 1200 mg of calcium daily. No clear difference between groups was found (p=0.58).

Study findings. At the two-year visit, cramps during the preceding six months were reported by 47% of men on placebo, 43% on 600 mg, and 51% on 1200 mg of calcium daily. No clear difference between groups was found (p=0.58).

Studied regimen600 or 1200 mg of elemental calcium/dayCalcium citrate
Duration and population2 years of use; at the two-year visit, participants were asked about cramps during the preceding 6 months323 healthy men aged 40 and over without osteoporosis, 107 on placebo, 108 in each calcium group

Comparison: placebo

Handgrip strength in men aged 40 and over2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: No CI for the contrast is reported. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Secondary outcome, cramps assessed by questionnaire.

Over two years in healthy men aged 40 and over without osteoporosis, no clear difference in the change in handgrip strength was found between calcium citrate and placebo.

Study findings. Over two years in healthy men aged 40 and over without osteoporosis, no clear difference in the change in handgrip strength was found between calcium citrate and placebo.

Studied regimen600 or 1200 mg of elemental calcium/dayCalcium citrate
Duration and population2 years323 healthy men aged 40 and over without osteoporosis, 107 on placebo, 108 in each calcium group

Comparison: placebo

Complete absence of leg cramps in pregnant women1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: 43 participants and an extremely wide interval. Consistency of results: One trial for this outcome; consistency cannot be determined. Applicability to the specified group: Pregnant women with cramps; do not extrapolate to other groups. Possible publication bias: Publication bias cannot be established from one study. Study methods: Open-label design and subjective outcome, randomization method unclear.

In a small open-label trial, pregnant women receiving calcium reported complete absence of leg cramps more often than women receiving no treatment. Certainty in this result is very low.

Study findings. In a small open-label trial, pregnant women receiving calcium reported complete absence of leg cramps more often than women receiving no treatment. Certainty in this result is very low.

Studied regimen1 g of calcium twice dailyoral mixture of calcium gluconate, lactate, and carbonate
Duration and population2 weeks43 pregnant women with leg cramps at least twice weekly; 9/22 versus 1/21 without cramps after treatment

Comparison: no treatment, no blinding

Frequency of leg cramps in pregnant women2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: One small study; limited reproducibility and information about the scale. Consistency of results: One trial for this outcome; consistency cannot be determined. Applicability to the specified group: Pregnant women with cramps; do not extrapolate to other groups. Possible publication bias: Publication bias cannot be established from one study. Study methods: Details available through the registry and review extraction; limited verification of conduct and a subjective outcome.

In a small study of pregnant women, leg cramps were slightly less frequent with calcium carbonate than with placebo.

Study findings. In a small study of pregnant women, leg cramps were slightly less frequent with calcium carbonate than with placebo.

Studied regimen500 mg of calcium carbonate once daily according to the Cochrane reviewCalcium carbonate
Duration and population4 weeks according to the description of Khoranrodi 2011 in the Cochrane review60 pregnant women in the third trimester with leg cramps

Comparison: placebo

Intensity of leg cramps in pregnant women1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: One small study, with an interval allowing opposite effects. Consistency of results: One trial for this outcome; consistency cannot be determined. Applicability to the specified group: Pregnant women with cramps; do not extrapolate to other groups. Possible publication bias: Publication bias cannot be established from one study. Study methods: Details available through the registry and review extraction; limited verification of conduct and a subjective outcome.

In a small study of pregnant women, no clear difference in leg cramp intensity was found between calcium carbonate and placebo.

Study findings. In a small study of pregnant women, no clear difference in leg cramp intensity was found between calcium carbonate and placebo.

Studied regimen500 mg of calcium carbonate once daily according to the Cochrane reviewCalcium carbonate
Duration and population4 weeks according to the description of Khoranrodi 2011 in the Cochrane review60 pregnant women in the third trimester with leg cramps

Comparison: placebo

Maximum squat strength in women who train1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: 31 participants, no precise interval for the interaction. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Several dependent outcomes and methods of analysis.

In one study, the gain in maximum squat strength was 5.62 kg greater with amorphous calcium carbonate than with placebo. Analysis of strength changes over time between groups did not confirm a consistent difference.

Study findings. In one study, the gain in maximum squat strength was 5.62 kg greater with amorphous calcium carbonate than with placebo. Analysis of strength changes over time between groups did not confirm a consistent difference.

Studied regimen1000 mg of the compound/dayAmorphous calcium carbonate
Duration and population9 weeks31 women doing resistance training

Comparison: Placebo, same training context

Maximum bench press strength in women who train1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: 31 participants, no precise interval for the interaction. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Several dependent outcomes and methods of analysis.

In one study of women who trained, no clear advantage of amorphous calcium carbonate over placebo was found for bench press strength.

Study findings. In one study of women who trained, no clear advantage of amorphous calcium carbonate over placebo was found for bench press strength.

Studied regimen1000 mg of the compound/dayAmorphous calcium carbonate
Duration and population9 weeks31 women doing resistance training

Comparison: Placebo, same training context

Systolic blood pressure with initially normal blood pressure3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

In people with normal blood pressure, increased calcium intake was associated with a small average reduction in systolic blood pressure compared with control.

Study findings. In people with normal blood pressure, increased calcium intake was associated with a small average reduction in systolic blood pressure compared with control.

Studied regimendoses and forms variedincreased calcium: supplements and fortified foods
Duration and populationfrom 4 weeks to 4 yearspeople with normal blood pressure, 18 RCTs, 3140 participants

Comparison: control

Diastolic blood pressure with initially normal blood pressure3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: No separate downgrade is required for the stated wording. Consistency of results: Moderate heterogeneity; effects varied by age and regimen. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast.

In people with normal blood pressure, increased calcium intake was associated with a small average reduction in diastolic blood pressure, about 1.5 mmHg, compared with control.

Study findings. In people with normal blood pressure, increased calcium intake was associated with a small average reduction in diastolic blood pressure, about 1.5 mmHg, compared with control.

Studied regimenDoses and salts variedCalcium supplements and one food-fortification experiment
Duration and population4 weeks–4 years3039 normotensive participants, 17 RCTs

Comparison: placebo or control

Total body weight with overweight or obesity2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

Calcium supplements showed no clear change in total body weight in people with overweight or obesity compared with placebo or a lower calcium dose.

Study findings. Calcium supplements showed no clear change in total body weight in people with overweight or obesity compared with placebo or a lower calcium dose.

Studied regimen162–1500 mg of elemental calcium/dayoral calcium supplements, different salts
Duration and populationmost studies shorter than 6 months1317 participants with overweight or obesity, 17 RCTs

Comparison: placebo or a lower calcium dose

Body mass index with overweight or obesity3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: No separate downgrade is required for the stated wording. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Quality limitations in the original RCTs.

The average reduction in body mass index with calcium compared with placebo or a lower calcium dose was small, about 0.18 kg/m².

Study findings. The average reduction in body mass index with calcium compared with placebo or a lower calcium dose was small, about 0.18 kg/m².

Studied regimen162–1500 mg of elemental calcium/day in the reviewCalcium salts alone
Duration and population8 weeks–24 months, most studies shorter than six monthsPeople with overweight or obesity, 731 in 9 RCTs

Comparison: placebo or a lower calcium dose

Waist circumference with overweight or obesity3/4 ModerateRead moreCollapse
Confidence
3/4 ModeratePrecision of the estimate: No separate downgrade is required for the stated wording. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Quality limitations in the original RCTs.

The average reduction in waist circumference with calcium compared with placebo or a lower calcium dose was small, about 0.51 cm.

Study findings. The average reduction in waist circumference with calcium compared with placebo or a lower calcium dose was small, about 0.51 cm.

Studied regimen162–1500 mg of elemental calcium/day in the reviewCalcium salts alone
Duration and population8 weeks–24 months, most studies shorter than six monthsPeople with overweight or obesity, 273 in 6 RCTs

Comparison: placebo or a lower calcium dose

Fat mass with overweight or obesity1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: The CI crosses zero. Consistency of results: I²=97%. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Quality limitations in the original RCTs.

The estimate of fat mass change allowed both a small decrease and a small increase with calcium compared with placebo or a lower calcium dose.

Study findings. The estimate of fat mass change allowed both a small decrease and a small increase with calcium compared with placebo or a lower calcium dose.

Studied regimen162–1500 mg of elemental calcium/day in the reviewCalcium salts alone
Duration and population8 weeks–24 months, most studies shorter than six monthsPeople with overweight or obesity, 812 in 12 RCTs

Comparison: placebo or a lower calcium dose

Tooth loss in older adults: calcium with vitamin D1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

In an additional analysis of older participants who completed a three-year study, loss of at least one tooth was reported less often with calcium and vitamin D than with placebo.

Study findings. In an additional analysis of older participants who completed a three-year study, loss of at least one tooth was reported less often with calcium and vitamin D than with placebo.

Studied regimen500 mg of calcium + 700 IU of D/daycalcium + vitamin D
Duration and population3 years145 older completers with available dental data

Comparison: placebo

Tooth loss in men: calcium alone1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: Only two events. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Secondary outcome, detection method not the primary one.

Over two years in a study of healthy men aged 40 and over, two people each lost one tooth: one on placebo and one on 600 mg of calcium. This is too little to determine the effect of calcium on tooth loss.

Study findings. Over two years in a study of healthy men aged 40 and over, two people each lost one tooth: one on placebo and one on 600 mg of calcium. This is too little to determine the effect of calcium on tooth loss.

Studied regimen600 or 1200 mg of elemental calcium/dayCalcium citrate
Duration and population2 years323 healthy men aged 40 and over without osteoporosis, 107 on placebo, 108 in each calcium group

Comparison: placebo

Lumbar spine and forearm bone density in breastfeeding women1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed.

A review of breastfeeding women found no clear overall difference in lumbar spine and forearm bone density between calcium and control.

Study findings. A review of breastfeeding women found no clear overall difference in lumbar spine and forearm bone density between calcium and control.

Studied regimen600 or 1000 mg of calcium daily in studies in the reviewCalcium supplements, forms varied
Duration and populationUse for at least 3 months; the review separately analyzed bone density changes at 3 and 6 monthsBreastfeeding women: 5 RCTs/567 in the review; lumbar spine BMD: 5 RCTs/527, forearm: 4 RCTs/415

Comparison: placebo or no supplement

Total hip bone density after childbirth1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: One experiment and limited size. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Open-label control, high risk of bias, allocation and reasons for missing data not confirmed.

In one study, total hip bone density increased more with calcium than without supplementation between three and 12 months after childbirth, mainly after breastfeeding had ended. Fractures were not assessed by this measure.

Study findings. In one study, total hip bone density increased more with calcium than without supplementation between three and 12 months after childbirth, mainly after breastfeeding had ended. Fractures were not assessed by this measure.

Studied regimen600 mg of calcium/dayCalcium carbonate without accompanying vitamin D
Duration and populationFrom 3 to 12 months after childbirth, most of the period after breastfeeding had ended160 women from Wuhan were selected, 112 in the analysis according to Cai (58/54); baseline dietary intake 562 ± 197 mg of calcium/day

Comparison: No supplement, open-label comparison

Safety and limitations

In the 2023 meta-analysis by Huo and colleagues, calcium without vitamin D showed no statistically significant increase in heart attack incidence: RR 1.15 (95% CI 0.88–1.51). A possible increase in risk is not excluded. The 2021 meta-analysis by Myung and colleagues found a different result. In the 2023 meta-analysis by Huo and colleagues, calcium combined with vitamin D showed no statistically significant increase in heart attack incidence: RR 1.09 (95% CI 0.95–1.25). The result applies to the combination; a possible increase in risk is not excluded. In the WHI study, 36 282 postmenopausal women received 1000 mg of elemental calcium as carbonate and 400 IU of vitamin D daily or placebo. Over an average of 7 years, diagnosed urinary tract stones were reported by 449 of 18 176 and 381 of 18 106 women, respectively; HR 1.17 (95% CI 1.02–1.34). The result applies to calcium combined with vitamin D. Calcium supplements may cause constipation, bloating, and gas. In a pooled analysis of seven studies, gastrointestinal complaints were reported by 716 of 5082 participants in calcium groups and 506 of 5046 in comparison groups; this combines complaints rather than representing the frequency of constipation. In one study, calcium was taken both with and without vitamin D. In the US, the tolerable upper intake level of elemental calcium from all sources is 2500 mg daily at ages 19–50 and 2000 mg from age 51. This is an upper limit, not an intake target. Hypercalcemia may be accompanied by constipation, nausea, and impaired kidney function and heart rhythm. For children, the tolerable upper intake level of calcium from food, drinks, and supplements is 1000 mg/day at 0–6 months, 1500 mg/day at 7–12 months, 2500 mg/day at 1–8 years, and 3000 mg/day at 9–18 years. These are not recommended supplement doses. With chronic kidney disease, the amount of calcium and need for supplementation are determined individually. For adults with CKD G3a–G5D, KDIGO recommends avoiding elevated blood calcium and limiting the dose of calcium-containing phosphate binders when treating elevated phosphate.

Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized Trials ↗ · Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials ↗ · Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements ↗ · Adverse events from calcium supplementation: Relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation ↗ · Calcium - Health Professional Fact Sheet ↗ · KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) — recommendation statements ↗

Interactions

WithEffectActionSource
Levothyroxine, for example SynthroidCalcium carbonate may reduce levothyroxine absorption.Take levothyroxine and the calcium carbonate supplement at least 4 hours apart; check the schedule against the instructions for the prescribed medicine.Calcium - Health Professional Fact Sheet ↗
Ciprofloxacin tablets — a quinolone antibioticCalcium may reduce ciprofloxacin absorption when taken at the same time.According to the cited ciprofloxacin tablet instructions, take the antibiotic at least 2 hours before a calcium supplement or no earlier than 6 hours after it; for another quinolone, check its own instructions.Calcium - Health Professional Fact Sheet ↗
CIPROFLOXACIN tablet, film coated — prescribing information ↗
Dolutegravir: Tivicay or Tivicay PDA calcium supplement taken at the same time on an empty stomach may substantially lower dolutegravir concentrations in the blood.Tivicay or Tivicay PD can be taken together with a calcium supplement with food; without food, take Tivicay or Tivicay PD at least 2 hours before calcium or 6 hours after it. Do not change the prescribed regimen without a doctor.Calcium - Health Professional Fact Sheet ↗
TIVICAY and TIVICAY PD — prescribing information ↗

Food sources

Calcium sources include dairy products, fish with edible bones, tofu, legumes, leafy greens, seeds, and fortified foods. Content depends on preparation, the tofu coagulant, and fortification; the amount in the table is not the amount absorbed. USDA SR28 data refer to 2015. Portions are selected comparison weights of the edible part in the specified state; calcium and calories are calculated from one food record. Check the current composition of fortified products on the package.

Dairy products

Plain low-fat yogurt, 8 ounces (about 227 g) — 415 mg; low-fat fruit yogurt, 8 ounces — 344 mg; nonfat milk, 1 US cup (about 240 ml) — 299 mg; whole milk with 3.25% fat, 1 cup — 276 mg; part-skim mozzarella, 1.5 ounces (about 43 g) — 333 mg.

Calcium - Health Professional Fact Sheet ↗

Fortified foods

Calcium-fortified orange juice, 1 cup (about 240 ml) — 349 mg; fortified soy drink, 1 cup — 299 mg; fortified breakfast cereal with 10% of the US daily value for calcium, 1 serving — 130 mg. Check the composition on the label.

Calcium - Health Professional Fact Sheet ↗

Tofu and legumes

Firm tofu prepared with calcium sulfate, ½ cup — 253 mg; soft tofu prepared with calcium sulfate, ½ cup — 138 mg; boiled soybeans, ½ cup — 131 mg; canned pinto beans, drained, ½ cup — 54 mg. For tofu, the value depends on the salt used in production.

Calcium - Health Professional Fact Sheet ↗

Leafy greens

Fresh kale after cooking, 1 cup — 94 mg; fresh boiled turnip greens, ½ cup — 99 mg; boiled spinach, drained, ½ cup — 123 mg. High oxalate content reduces the fraction of calcium absorbed from spinach.

Calcium - Health Professional Fact Sheet ↗

Fish with bones

Sardines canned in oil with bones, 3 ounces (about 85 g) — 325 mg; canned pink salmon, solids with bones, 3 ounces — 181 mg.

Calcium - Health Professional Fact Sheet ↗

Food composition

FoodGroupAmountServingCaloriesSources
Plain yogurtplain low-fat, 12 g of protein per 8 ouncesDairy products183 mg of calcium / 100 g170 g · 311.1 mg of calcium · 107.1 kcalSelected comparison weight: 170 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.63 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 01 ↗
Nonfat milkfluid, nonfat, with added vitamins A and DDairy products122 mg of calcium / 100 g245 g · 298.9 mg of calcium · 83.3 kcalSelected comparison weight: 245 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.34 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 01 ↗
Mozzarellamade from part-skim milkDairy products782 mg of calcium / 100 g28 g · 218.96 mg of calcium · 71.12 kcalSelected comparison weight: 28 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.254 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 01 ↗
Firm tofufirm; coagulants calcium sulfate and magnesium chloride (nigari)Tofu and legumes201 mg of calcium / 100 g126 g · 253.26 mg of calcium · 98.28 kcalSelected comparison weight: 126 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.78 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
Soft tofusoft; coagulants calcium sulfate and magnesium chloride (nigari)Tofu and legumes111 mg of calcium / 100 g120 g · 133.2 mg of calcium · 73.2 kcalSelected comparison weight: 120 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.61 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
Soy drinkplain or vanilla, with added calcium and vitamins A and DFortified foods123 mg of calcium / 100 g243 g · 298.89 mg of calcium · 104.49 kcalSelected comparison weight: 243 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.43 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
Soybeansmature seeds, boiled with saltTofu and legumes102 mg of calcium / 100 g86 g · 87.72 mg of calcium · 147.92 kcalSelected comparison weight: 86 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.172 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
Pinto beanscanned, drained solidsTofu and legumes63 mg of calcium / 100 g138 g · 86.94 mg of calcium · 157.32 kcalSelected comparison weight: 138 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.114 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
Kaleboiled, drained, without saltLeafy greens and vegetables72 mg of calcium / 100 g130 g · 93.6 mg of calcium · 36.4 kcalSelected comparison weight: 130 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.28 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
Spinachboiled, drained, without saltLeafy greens and vegetables136 mg of calcium / 100 g90 g · 122.4 mg of calcium · 20.7 kcalSelected comparison weight: 90 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.23 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
Turnip greensboiled, drained, without saltLeafy greens and vegetables137 mg of calcium / 100 g72 g · 98.64 mg of calcium · 14.4 kcalSelected comparison weight: 72 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.20 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
Broccoliboiled, drained, without saltLeafy greens and vegetables40 mg of calcium / 100 g78 g · 31.2 mg of calcium · 27.3 kcalSelected comparison weight: 78 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.35 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
Corn Chex cerealGeneral Mills dry corn cereal; USDA 2015 compositionFortified foods323 mg of calcium / 100 g31 g · 100.13 mg of calcium · 114.7 kcalSelected comparison weight: 31 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.370 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 08 ↗
Atlantic sardinescanned in oil, drained solids, with bonesFish with bones382 mg of calcium / 100 g85 g · 324.7 mg of calcium · 176.8 kcalSelected comparison weight: 85 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.208 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Pink salmoncanned without salt, solids with bones and liquidFish with bones213 mg of calcium / 100 g85 g · 181.05 mg of calcium · 118.15 kcalSelected comparison weight: 85 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.139 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Chia seedsdried seedsSeeds631 mg of calcium / 100 g28 g · 176.68 mg of calcium · 136.08 kcalSelected comparison weight: 28 g of edible portion in the specified state; calcium and calories are calculated from values per 100 g in a single record. This is a calculated serving example, not a USDA standard.486 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 12 ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Calcium intake and bone mineral density: systematic review and meta-analysis ↗Bone mineral density in adults over 50adults over 50, review of 59 RCTs, 51 supplement comparisonscalcium supplements, some with vitamin D; various doses, salts, and background vitamin D intake; sites and durations varied, including 1–2 years; comparison: control in individual trialsIn a review of adults over 50, calcium supplements, with vitamin D in some studies, were associated with a small increase in bone density. Fractures need to be assessed separately.
Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗Any fracture: calcium with vitamin D: Any fracture: calcium with vitamin D Hip fractures: calcium with vitamin D: Hip fractures: calcium with vitamin D Any fracture: calcium alone: Any fracture: calcium alone Hip fractures: calcium alone: Hip fractures: calcium alone Nonvertebral fractures: calcium alone: Nonvertebral fractures: calcium alone Vertebral fractures: calcium alone: Vertebral fractures: calcium alone At least one fall: calcium alone: At least one fall: calcium alone Rate of falls: calcium alone: Rate of falls: calcium alone Nonvertebral fractures: calcium with vitamin D: Nonvertebral fractures: calcium with vitamin D Vertebral fractures: calcium with vitamin D: Vertebral fractures: calcium with vitamin D At least one fall: calcium with vitamin D: At least one fall: calcium with vitamin D Rate of falls: calcium with vitamin D: Rate of falls: calcium with vitamin DAny fracture: calcium with vitamin D: 15 RCTs, 51 126 participants, predominantly living at home Hip fractures: calcium with vitamin D: adults in combination trials, predominantly living at home Any fracture: calcium alone: Adults, predominantly living at home, 9067 in 11 RCTs Hip fractures: calcium alone: Adults, predominantly living at home, 6703 in 6 RCTs Nonvertebral fractures: calcium alone: Adults, predominantly living at home, 3204 in 4 RCTs Vertebral fractures: calcium alone: Adults, predominantly living at home, 6576 in 10 RCTs At least one fall: calcium alone: Adults, predominantly living at home, 2966 in 2 RCTs Rate of falls: calcium alone: Adults, predominantly living at home, 1794 in 2 RCTs Nonvertebral fractures: calcium with vitamin D: Adults, predominantly living at home, 10324 in 7 RCTs Vertebral fractures: calcium with vitamin D: Adults, predominantly living at home, 42185 in 4 RCTs At least one fall: calcium with vitamin D: Adults, predominantly living at home, 11068 in 10 RCTs Rate of falls: calcium with vitamin D: Adults, predominantly living at home, 7532 in 4 RCTsAny fracture: calcium with vitamin D: calcium plus vitamin D; doses and forms varied; individual trial durations varied; comparison: placebo or no supplement Hip fractures: calcium with vitamin D: calcium plus vitamin D; various doses; trial durations varied; comparison: placebo or no supplement Any fracture: calcium alone: Calcium supplements alone, various salts; Doses varied; Durations varied, averaging 2.8 years in 15 calcium studies; comparison: Placebo or no supplement Hip fractures: calcium alone: Calcium supplements alone, various salts; Doses varied; Durations varied, averaging 2.8 years in 15 calcium studies; comparison: Placebo or no supplement Nonvertebral fractures: calcium alone: Calcium supplements alone, various salts; Doses varied; Durations varied, averaging 2.8 years in 15 calcium studies; comparison: Placebo or no supplement Vertebral fractures: calcium alone: Calcium supplements alone, various salts; Doses varied; Durations varied, averaging 2.8 years in 15 calcium studies; comparison: Placebo or no supplement At least one fall: calcium alone: Calcium supplements alone, various salts; Doses varied; Durations varied, averaging 2.8 years in 15 calcium studies; comparison: Placebo or no supplement Rate of falls: calcium alone: Calcium supplements alone, various salts; Doses varied; Durations varied, averaging 2.8 years in 15 calcium studies; comparison: Placebo or no supplement Nonvertebral fractures: calcium with vitamin D: Calcium together with vitamin D; Doses and forms varied; Durations varied; comparison: Placebo or no supplement Vertebral fractures: calcium with vitamin D: Calcium together with vitamin D; Doses and forms varied; Durations varied; comparison: Placebo or no supplement At least one fall: calcium with vitamin D: Calcium together with vitamin D; Doses and forms varied; Durations varied; comparison: Placebo or no supplement Rate of falls: calcium with vitamin D: Calcium together with vitamin D; Doses and forms varied; Durations varied; comparison: Placebo or no supplementAny fracture: calcium with vitamin D: Calcium combined with vitamin D slightly reduced the risk of any fracture compared with placebo or no supplement. After one influential trial was excluded, the result became uncertain. Hip fractures: calcium with vitamin D: In the groups studied, calcium combined with vitamin D showed a small average reduction in hip fracture risk compared with placebo or no supplement. Any fracture: calcium alone: No clear reduction in the risk of any fracture was found with calcium alone compared with placebo or no supplement. Hip fractures: calcium alone: The effect of calcium alone on hip fracture risk remains very uncertain. Nonvertebral fractures: calcium alone: In the calcium-alone analysis, the estimate of nonvertebral fracture risk allowed both a decrease and an increase compared with control. Vertebral fractures: calcium alone: In the calcium-alone analysis, the estimate of vertebral fracture risk allowed both a decrease and an increase compared with control. At least one fall: calcium alone: No clear reduction in the probability of at least one fall was found with calcium alone compared with placebo or no supplement. Rate of falls: calcium alone: No clear reduction in the rate of falls was found with calcium alone compared with placebo or no supplement. Nonvertebral fractures: calcium with vitamin D: In the overall analysis, calcium with vitamin D reduced nonvertebral fracture risk compared with control. After one influential trial was excluded, the reduction became uncertain. Vertebral fractures: calcium with vitamin D: The estimate of vertebral fracture risk with calcium and vitamin D allowed both a decrease and an increase compared with control. At least one fall: calcium with vitamin D: A reduction in the probability of at least one fall with calcium and vitamin D compared with control remains uncertain. Rate of falls: calcium with vitamin D: No clear difference in the rate of falls was found between calcium combined with vitamin D and control.

Sources

Sources
  1. Calcium intake and bone mineral density: systematic review and meta-analysis ↗
  2. Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
  3. Calcium supplementation for improving bone mineral density in children ↗
  4. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms ↗
  5. Effects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗
  6. Randomized Controlled Trial of Calcium Supplementation in Healthy, Nonosteoporotic, Older Men ↗
  7. Interventions for leg cramps in pregnancy ↗
  8. The Effects of Amorphous Calcium Carbonate (ACC) Supplementation on Resistance Exercise Performance in Women ↗
  9. Calcium supplementation for prevention of primary hypertension ↗
  10. Calcium supplementation for people with overweight or obesity ↗
  11. Calcium and vitamin D supplements reduce tooth loss in the elderly ↗
  12. Calcium supplementation for improving bone density in lactating women: a systematic review and meta-analysis of randomized controlled trials ↗
  13. Effect of calcium supplementation on the regain of BMD in Chinese lactating women with 4 major combined ER genotypes ↗
  14. Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized Trials ↗
  15. Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials ↗
  16. Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements ↗
  17. Calcium - Health Professional Fact Sheet ↗
  18. Adverse events from calcium supplementation: Relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation ↗
  19. TIVICAY (dolutegravir) tablets and TIVICAY PD (dolutegravir) tablets for oral suspension — Full Prescribing Information ↗
  20. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) — recommendation statements ↗
  21. CIPROFLOXACIN tablet, film coated — prescribing information ↗
  22. TIVICAY and TIVICAY PD — prescribing information ↗
  23. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 01 ↗
  24. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
  25. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
  26. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 08 ↗
  27. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
  28. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 12 ↗